SBRA — Sabra Health Care REIT, Inc.

Summary of Sabra Health Care REIT, Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Normalized FFO per share: $0.36; Normalized AFFO per share: $0.38.
• Total Normalized FFO: $91.2 million; Normalized AFFO: $95.2 million for Q4.
• Cash NOI from the triple net portfolio decreased by $1.3 million sequentially, while cash NOI from the managed senior housing portfolio increased by $5.5 million.
• Net debt to adjusted EBITDA ratio: 5.00 times, consistent with the target leverage.
• Dividend declared: $0.30 per share, representing a payout ratio of 79% of Q4 normalized AFFO.

2. Strategic Updates and Business Highlights

• Investment Activity: Completed approximately $450 million in investments for 2025, with an expectation to exceed this volume in 2026. Currently closing $240 million in awarded deals.
• Operational Performance: Strong occupancy gains in the SHOP portfolio, with same-store senior housing revenue growth of 6.4% year-over-year and occupancy up to 87.9%.
• Managed Senior Housing Portfolio: Revenue growth of 15.8% and cash NOI growth of 18.4% in Q4, indicating strong operational results.
• Regulatory Environment: Remains stable, with no significant concerns reported.

3. Forward Guidance and Outlook

• 2026 Guidance:
  • Normalized FFO per share: $1.49 to $1.53; Normalized AFFO per share: $1.55 to $1.59, reflecting a 5% increase over 2025.
  • Cash NOI growth: Expected low single digits for the triple net portfolio, while same-store managed senior housing is projected to grow in the low to mid-teens.
  • General and Administrative Expenses: Expected to be approximately $52 million, including $12 million in stock-based compensation.

4. Bad News, Challenges, or Points of Concern

• Cash NOI Decline: The transition of four facilities from triple net to managed housing negatively impacted cash NOI from the triple net portfolio.
• Interest and Other Income: Decreased to $10.6 million from $12.7 million in the previous quarter, primarily due to lease termination income recognized last quarter.
• Competition: Increased competition in the SHOP sector may pressure returns, although Sabra continues to find high-quality assets.
• Occupancy Challenges: The Holiday transition assets are lagging behind other portfolios, although they are expected to improve over time.

5. Notable Q&A Insights

• Occupancy Growth: Management expects occupancy in the same-store portfolio to reach the low 90s, with potential for further growth.
• Investment Focus: 95% of the $240 million in awarded deals is expected to be in SHOP, with limited skilled nursing investments.
• Regulatory Outlook: No significant concerns regarding Medicaid and Medicare rates, with expectations for rates to stabilize.
• Operational Expertise: Management emphasized the advantage of having an experienced team in operations, which is crucial for navigating the complexities of the SHOP sector.

This summary encapsulates the key aspects of Sabra Health Care REIT's Q4 2025 earnings call, highlighting both the positive developments and the challenges the company faces moving forward.